NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Equillium Inc (F: 0FY)

 
0FY Technical Analysis
4
As on 20th Nov 2024 0FY STOCK Price closed @ 0.68 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.98 & Sell for SHORT-TERM with Stoploss of 0.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

0FYSTOCK Price

Open 0.68 Change Price %
High 0.68 1 Day -0.48 -41.38
Low 0.68 1 Week -0.52 -43.33
Close 0.68 1 Month -0.01 -1.45
Volume 1080 1 Year 0.10 17.24
52 Week High 2.70 | 52 Week Low 0.42
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
CMID 0.00 -100.00%
CMID 0.00 -100.00%
CMID 0.00 -100.00%
3MW 0.00 -100.00%
3MW 0.00 -100.00%
BRTN 0.00 -100.00%
BRTN 0.00 -100.00%
2TU 0.00 -100.00%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
 
 
0FY
Daily Charts
0FY
Intraday Charts
Whats New @
Bazaartrend
0FY
Free Analysis
 
0FY Important Levels Intraday
RESISTANCE0.68
RESISTANCE0.68
RESISTANCE0.68
RESISTANCE0.68
RESISTANCE0.68
RESISTANCE0.68
RESISTANCE0.68
RESISTANCE0.68
 
0FY Forecast November 2024
4th UP Forecast1.07
3rd UP Forecast0.94
2nd UP Forecast0.87
1st UP Forecast0.79
1st DOWN Forecast0.57
2nd DOWN Forecast0.49
3rd DOWN Forecast0.42
4th DOWN Forecast0.29
 
0FY Weekly Forecast
4th UP Forecast0.80
3rd UP Forecast0.76
2nd UP Forecast0.74
1st UP Forecast0.71
1st DOWN Forecast0.65
2nd DOWN Forecast0.62
3rd DOWN Forecast0.60
4th DOWN Forecast0.56
 
0FY Forecast2024
4th UP Forecast5.11
3rd UP Forecast3.69
2nd UP Forecast2.81
1st UP Forecast1.93
1st DOWN Forecast-0.57
2nd DOWN Forecast-1.45
3rd DOWN Forecast-2.33
4th DOWN Forecast-3.75
 
 
0FY Other Details
Segment EQ
Market Capital 145065712.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
0FY Address
0FY
 
0FY Latest News
 
Your Comments and Response on Equillium Inc
 
0FY Business Profile
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase 1b/2 clinical trials for the treatment of acute graft-versus-host disease; and Phase 1 clinical trial for the treatment of asthma and lupus nephritis. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Address: 2223 Avenida De La Playa, La Jolla, CA, United States, 92037
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service